Suppr超能文献

纳米级功能 miRNA 脂质体及其通过沉默 Slug 基因治疗三阴性乳腺癌的应用。

Nanosized functional miRNA liposomes and application in the treatment of TNBC by silencing Slug gene.

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug System, and School of Pharmaceutical Sciences, Peking University, Beijing, People's Republic of China.

出版信息

Int J Nanomedicine. 2019 May 17;14:3645-3667. doi: 10.2147/IJN.S207837. eCollection 2019.

Abstract

Neo-adjuvant chemotherapy is an effective strategy for improving treatment of breast cancers. However, the efficacy of this treatment strategy is limited for treatment of triple negative breast cancer (TNBC). Gene therapy may be a more effective strategy for improving the prognosis of TNBC. A novel 25 nucleotide sense strand of miRNA was designed to treat TNBC by silencing the Slug gene, and encapsulated into DSPE-PEG-tLyp-1 peptide-modified functional liposomes. The efficacy of miRNA liposomes was evaluated on invasive TNBC cells and TNBC cancer-bearing nude mice. Furthermore, functional vinorelbine liposomes were constructed to investigate the anticancer effects of combined treatment. The functional miRNA liposomes had a round shape and were nanosized (120 nm). Functional miRNA liposomes were effectively captured by TNBC cells in vitro and were target to mitochondria. Treatment with functional liposomes silenced the expression of and Slug protein, inhibited the TGF-β1/Smad pathway, and inhibited invasiveness and growth of TNBC cells. In TNBC cancer-bearing mice, functional miRNA liposomes exerted a stronger anticancer effect than functional vinorelbine liposomes, and combination therapy with these two formulations resulted in nearly complete inhibition of tumor growth. Preliminary safety evaluations indicated that the functional miRNA liposomes did not affect body weight or cause damage to any major organs. Furthermore, the functional liposomes significantly increased the half-life of the drug in the blood of cancer-bearing nude mice, and increased drug accumulation in breast cancer tissues. In this study, we constructed novel functional miRNA liposomes. These liposomes silenced Slug expression and inhibited the TGF-β1/Smad pathway in TNBC cells, and enhanced anticancer efficacy in mice using combined chemotherapy. Hence, the present study demonstrated a promising strategy for gene therapy of invasive breast cancer.

摘要

新辅助化疗是改善乳腺癌治疗的有效策略。然而,这种治疗策略对三阴性乳腺癌(TNBC)的疗效有限。基因治疗可能是改善 TNBC 预后的更有效策略。设计了一种新型的 25 个核苷酸的 miRNA 正义链,通过沉默 Slug 基因来治疗 TNBC,并将其包裹在 DSPE-PEG-tLyp-1 肽修饰的功能性脂质体中。在侵袭性 TNBC 细胞和 TNBC 荷瘤裸鼠上评估了 miRNA 脂质体的疗效。此外,构建了功能性长春瑞滨脂质体,以研究联合治疗的抗癌作用。功能性 miRNA 脂质体呈圆形,纳米级(120nm)。功能性 miRNA 脂质体在体外能被 TNBC 细胞有效捕获,并靶向线粒体。用功能性脂质体处理可沉默基因和 Slug 蛋白的表达,抑制 TGF-β1/Smad 通路,并抑制 TNBC 细胞的侵袭和生长。在 TNBC 荷瘤小鼠中,功能性 miRNA 脂质体的抗癌作用强于功能性长春瑞滨脂质体,两种制剂联合治疗可使肿瘤生长几乎完全受到抑制。初步安全性评估表明,功能性 miRNA 脂质体不影响体重,也不会对任何主要器官造成损害。此外,功能性脂质体显著延长了荷瘤裸鼠血液中药物的半衰期,并增加了药物在乳腺癌组织中的积累。在本研究中,我们构建了新型功能性 miRNA 脂质体。这些脂质体沉默 Slug 表达,抑制 TNBC 细胞中的 TGF-β1/Smad 通路,并通过联合化疗增强了小鼠的抗癌疗效。因此,本研究为侵袭性乳腺癌的基因治疗提供了一种有前途的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2309/6529035/8296453b2c06/IJN-14-3645-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验